Innovent Biologics Inc
OTC:IVBIY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innovent Biologics Inc
OTC:IVBIY
|
CN |
|
Artec Technologies AG
F:A6T
|
DE |
|
K
|
Kolibri Global Energy Inc
F:B12
|
US |
|
C
|
CRA International Inc
F:CR2
|
US |
|
HYTN Innovations Inc
F:85W0
|
CA |
|
Glory Ltd
F:3O5
|
JP |
|
T
|
Treatt PLC
F:5TT
|
UK |
|
A
|
Albis Leasing AG
XHAM:ALG
|
DE |
|
A
|
Artec Technologies AG
XBER:A6T
|
DE |
|
Immofinanz AG
LSE:0PAN
|
AT |
|
John Cockerill India Ltd
NSE:COCKERILL
|
IN |
|
S
|
Schaeffler AG
XHAN:SHA0
|
DE |
|
W
|
Westmount Energy Ltd
SWB:W6M
|
JE |
|
Borussia Dortmund GmbH & Co KGaA
XETRA:BVB
|
DE |
|
F
|
Fuyo General Lease Co Ltd
F:FXL
|
JP |
|
B
|
Bank of East Asia Ltd
OTC:BKEAF
|
HK |
|
Metro Mining Ltd
ASX:MMIDA
|
AU |
|
Trident Royalties PLC
F:5KV
|
UK |
|
Imagin Medical Inc
F:DPD3
|
CA |
|
A
|
Allied Energy Inc
OTC:AGGI
|
US |
|
A
|
Avillion Bhd
KLSE:AVI
|
MY |
|
Link Net Tbk PT
IDX:LINK
|
ID |
|
C
|
Coma 18 JSC
VN:CIG
|
VN |
|
Spineguard SA
PAR:ALSGD
|
FR |
Wall St Price Targets
IVBIY Price Targets Summary
Innovent Biologics Inc
According to Wall Street analysts, the average 1-year price target for IVBIY is 67.43 USD with a low forecast of 50.29 USD and a high forecast of 83.12 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IVBIY's stock price target?
Price Target
67.43
USD
According to Wall Street analysts, the average 1-year price target for IVBIY is 67.43 USD with a low forecast of 50.29 USD and a high forecast of 83.12 USD.
What is the Revenue forecast for Innovent Biologics Inc?
Projected CAGR
20%
Over the last 8 years, the compound annual growth rate for Revenue has been 127%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Innovent Biologics Inc?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 8 years is 20%.
What is the Operating Income forecast for Innovent Biologics Inc?
Projected CAGR
44%
The compound annual growth rate for Operating Income over the next 8 years is 44%.
What is the Pre-Tax Income forecast for Innovent Biologics Inc?
Projected CAGR
89%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 89%.
What is the Net Income forecast for Innovent Biologics Inc?
Projected CAGR
36%
The compound annual growth rate for Net Income over the next 8 years is 36%.
